EcoDrugPlus

Lysine Demethylase 1a

Ensembl ID : ENSCMIG00000016497
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Homolog 2-Like

Ensembl ID : ENSCMIG00000006689
Gene Symbol: LOC103189748
3 Cross references
288 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCMIG00000003525
Gene Symbol: MIF
3 Cross references
235 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSCMIG00000017940
Gene Symbol: MST1R
2 Cross references
268 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSCMIG00000006020
Gene Symbol: MMP1
1 Cross references
139 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSCMIG00000017829
Gene Symbol: MMP2
4 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSCMIG00000005999
Gene Symbol: MMP7
3 Cross references
170 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSCMIG00000014451
Gene Symbol: MMP9
4 Cross references
219 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSCMIG00000002515
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSCMIG00000015191
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSCMIG00000013902
Gene Symbol: MC3R
1 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSCMIG00000014904
Gene Symbol: MC4R
4 Cross references
229 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).